Dr Reddy's to make trial quantities of Cellceutix's psoriasis candidate
This article was originally published in Scrip
Executive Summary
Cellceutix Corporation, a clinical stage biopharmaceutical firm focused on discovering small molecule drugs for cancer, autism and psoriasis, has tied up with Dr Reddy's Laboratories for manufacturing its new drug candidate for the treatment of psoriasis, Prurisol.